Biosimilars

ARTICLES

Scientists at the FDA have provided their recommendation to be submitted to an independent medical advisory panel that will decide the fate of Remsima.
What we're reading, January 8, 2016: HHS releases report with full Obamacare enrollment information for all 50 states and the District of Columbia; the expansion of the biosimilars in 2016; and promising Ebola treatment found not effective.
An update on where the field of biosimilars currently stands.
The most read articles in The American Journal of Managed Care's Evidence-Based Oncology ranged from personal narratives to healthcare policy issues that impact the broader population.

MULTIMEDIA



Feature
Diabetes Compendium
Oncology Compendium
COPD Compendium
Reimbursement Compendium
$AD300x250BB$
$vacMongoViewPlus$